N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide
TL;DR: N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide (CAS 370844-75-0) is a chemical compound with molecular formula C19H23IN4O2 and molecular weight 466.09 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(E)-[1-(4-iodophenyl)-2,5-dimethylpyrrol-3-yl]methylideneamino]-2-morpholin-4-ylacetamide
Also Known As: N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide, (E)-N'-((1-(4-iodophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-morpholinoacetohydrazide, N'-{(E)-[1-(4-iodophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-2-(morpholin-4-yl)acetohydrazide, N-[(E)-[1-(4-iodophenyl)-2,5-dimethylpyrrol-3-yl]methylideneamino]-2-morpholin-4-ylacetamide
| Molecular Formula | C19H23IN4O2 |
|---|---|
| Molecular Weight | 466.09 g/mol |
| LogP | 2.48104 |
| Topological Polar Surface Area | 58.86 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Exact Mass | 466.08658 |
| Heavy Atoms | 26 |
| Complexity | 792.6156 |
Chemical Identifiers
| CAS Number | 370844-75-0 |
|---|---|
| SMILES | CC1=CC(=C(N1C2=CC=C(C=C2)I)C)/C=N/NC(=O)CN3CCOCC3 |
Product Overview
N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide (CAS 370844-75-0), with molecular formula C19H23IN4O2 and molecular weight 466.09 g/mol. IUPAC: N-[(E)-[1-(4-iodophenyl)-2,5-dimethylpyrrol-3-yl]methylideneamino]-2-morpholin-4-ylacetamide.
Chemical Property Profile of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide
Property Insights of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide
The XLogP value of 2.48104 suggests moderate lipophilicity, balancing water solubility and membrane permeability for N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide. With a topological polar surface area (TPSA) of 58.86 Ų, N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide has 1 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide?
The CAS number of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide is 370844-75-0.
What is the molecular formula of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide?
The molecular formula of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide is C19H23IN4O2.
What is the molecular weight of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide?
The molecular weight of N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide is 466.09 g/mol.
Where can I buy N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide?
You can request a quote for N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-[[1-(4-iodophenyl)-2,5-dimethyl-pyrrol-3-yl]methylideneamino]-2-morpholin-4-yl-acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.